The results of the UALCAN database showed that the expression of the hub genes TSR1, HSP90AA1, and NOP56 increased gradually with the advancing clinical stage of DLBCL patients, but there was no statistical significance (P > 0.05). Here, TSR1 is linked to diffuse large B-cell lymphoma.